Letrozole
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (National)
1.2M
NHS Cost
£4.1M
Practices
6,444
Avg per Practice
187
Overview
Letrozole is prescribed by 6,444 GP practices across England. In the last 12 months, 1,203,314 items were prescribed at a total cost of £4,119,326 to the NHS. It is classified under BNF Chapter Malignant Disease and Immunosuppression, Section Sex hormones and hormone antagonists in malignant disease.
Monthly Prescribing Trend
Jun 2026
99,041
Jun 2026
92,299
Jun 2026
101,269
Jun 2026
98,688
Jun 2026
95,225
Jun 2026
101,695
Jun 2026
97,615
Jun 2026
101,287
Jun 2026
102,088
Jun 2026
92,124
Jun 2026
96,078
Jun 2026
99,657
Prescribing by Area
| Area | Items | Practices | Avg/Practice | vs National |
|---|---|---|---|---|
| S | 51.8K | 164 | 316 | +69.3% ▲ |
| NE | 44.4K | 138 | 322 | +72.4% ▲ |
| M | 31.0K | 170 | 183 | -2.2% ▼ |
| B | 24.1K | 237 | 102 | -45.5% ▼ |
| BS | 22.2K | 79 | 281 | +50.4% ▲ |
| TS | 22.0K | 72 | 306 | +63.7% ▲ |
| L | 22.0K | 141 | 156 | -16.5% ▼ |
| CV | 21.9K | 108 | 203 | +8.5% ▲ |
| CM | 21.2K | 66 | 322 | +72.4% ▲ |
| LE | 21.2K | 116 | 183 | -2.2% ▼ |
| PE | 20.3K | 91 | 223 | +19.2% ▲ |
| IP | 19.9K | 59 | 337 | +80.2% ▲ |
| PO | 19.8K | 62 | 319 | +71.0% ▲ |
| TN | 19.7K | 71 | 277 | +48.5% ▲ |
| DN | 19.7K | 85 | 231 | +23.9% ▲ |
| BN | 19.1K | 75 | 254 | +36.2% ▲ |
| SW | 19.0K | 110 | 173 | -7.3% ▼ |
| N | 18.7K | 116 | 162 | -13.5% ▼ |
| SK | 18.6K | 71 | 262 | +40.5% ▲ |
| BB | 18.5K | 67 | 277 | +48.1% ▲ |
Top Prescribing Practices
| Practice | Items |
|---|---|
| VALENS MEDICAL PARTNERSHIP | 1,846 |
| MEDICUS HEALTH PARTNERS | 1,778 |
| GRANTA MEDICAL PRACTICES | 1,725 |
BNF Classification
- Chapter: Malignant Disease and Immunosuppression
- Section: Sex hormones and hormone antagonists in malignant disease
- Paragraph: Hormone antagonists
Related drugs in this section
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.